DeLorean AI specializes in developing advanced intelligent systems for Fortune 500 companies. Its patent-pending machines, algorithms, and systems have been developed to predict real-time revenue-generating outcomes and comprise a product portfolio that includes:
1. Medical AI: To manage chronic diseases by predicting outcomes, generating next-best actions, and presenting user-friendly results
2. Ticket Analysis Prediction Engine AI (Tape AI): An intelligent system for IT operations
3. Sales AI: A sales intelligence platform
The Sales AI solution aims to streamline sales and customer relationship management. It uses both structured and unstructured data within CRM systems, enabling comprehensive analysis. The system aims to predict deal outcomes, identify key drivers, recommend next-best actions, and intervene to increase the probability of winning deals. The system then builds horizon datasets and creates profiles, including customer, deal, salesperson, and event details. DeLorean AI's Sales AI provides real-time insights through customizable dashboards, enabling sales executives and managers to make informed decisions. The platform also integrates with CRM platforms and is compatible with tools such as PowerBI and Tableau.
The company claims that DeLorean AI clients have seen a 15% increase in sales with the adaptation of Sales AI.
Funding and financials
In September 2023 , DeLorean AI raised USD 7.55 million in a Series A funding round led by Sopris Ventures to expand its team by 50% within the following two months, hiring in areas such as sales, marketing, and data science.
No investor data is available
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.